10. Which people with type 2 diabetes would benefit from SGLT-2 inhibitors and GLP-1 receptor agonists?

Update: 2020-11-25

Description

Listen to Professor Liebl outline when and how he uses these modern agents.
Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.

Comments

In Channel

1. When and how to initiate insulin

2020-11-2607:17

2. How to support people earlier in living with diabetes

2020-11-2609:12

3. Sulphonylureas and managing hypoglycaemia in practice

2020-11-2609:53

4. Why should I treat more intensively earlier?

2020-11-2606:12

5. Can GLP-1 receptor agonists and SGLT-2 inhibitors be used together?

2020-11-2508:56

6. The key role of primary care in type 2 diabetes

2020-11-2505:30

7. An exciting time ahead for primary care physicians in diabetes

2020-11-2503:56